Squarepoint’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-35,606
| Closed | -$39.5K | – | 2944 |
|
|
2022
Q4 | $39.5K | Buy |
+35,606
| New | +$39.5K | ﹤0.01% | 2162 |
|
|
2022
Q1 | – | Sell |
-11,054
| Closed | -$92K | – | 3033 |
|
|
2021
Q4 | $92K | Sell |
11,054
-2,888
| -21% | -$24K | ﹤0.01% | 2326 |
|
|
2021
Q3 | $104K | Sell |
13,942
-50,023
| -78% | -$373K | ﹤0.01% | 1996 |
|
|
2021
Q2 | $435K | Buy |
63,965
+51,891
| +430% | +$353K | ﹤0.01% | 1708 |
|
|
2021
Q1 | $124K | Sell |
12,074
-73,860
| -86% | -$759K | ﹤0.01% | 2310 |
|
|
2020
Q4 | $602K | Buy |
85,934
+53,997
| +169% | +$378K | ﹤0.01% | 1375 |
|
|
2020
Q3 | $261K | Buy |
+31,937
| New | +$261K | ﹤0.01% | 1781 |
|
|
2019
Q1 | – | Sell |
-76,457
| Closed | -$258K | – | 2465 |
|
|
2018
Q4 | $258K | Buy |
76,457
+53,948
| +240% | +$182K | ﹤0.01% | 1552 |
|
|
2018
Q3 | $146K | Buy |
+22,509
| New | +$146K | ﹤0.01% | 1830 |
|